Nateglinide was very well tolerated. The overall incidence of AEs, other than symptoms of hypoglycemia, was low and similar among all treatment groups. No deaths occurred during the study ...

The goal of this study was to assess the safety, tolerability, and metabolic effects of nateglinide in a prediabetic population and to thereby establish the feasibility of using nateglinide for a ...